Prostate Cancer Clinical Trial
Official title:
A Bio-psychosocial Sexual Health Intervention for Prostate Cancer Survivors and Partners: a Feasibility Study
The burden of sexual dysfunction after prostate cancer surgery is responsible for the single greatest impact on patient/partner health-related quality of life; substantially more so than concern for cancer recurrence, or any other post-surgery side-effect. Consequently, there is a great need for progressive and distributable sexual health rehabilitation interventions designed to uphold intimacy and optimal sexual health. If the biomedical-psychosocial intervention is ultimately found beneficial, it will result in: 1) an empirically-based intervention that helps patients/partners maintain optimal health-related quality of life after prostate cancer surgery, and 2) a highly structured protocol and manualized intervention that is translatable to other treatment groups (e.g. radiation therapy) and University/Community-based hospitals.
Previous Research: The prevalence of sexual dysfunction (SD) after prostate cancer surgery,
coupled with the severity of impact and lack of successful intervention, make SD one of the
most substantial health-related quality of life burdens in all of cancer survivorship. In
2012, 21,000 men will be added to the pool of Canadian prostate cancer (PC) survivors.
Approximately 70% of men will suffer SD post-surgery and 60% will experience significant
distress in response to SD. Similarly, partners may experience even greater distress than
patients. Research examining the nature of the distress reveals that the significance of SD
extends beyond the ability to have an erection, and includes guilt, depression, anxiety,
anger, and reductions in intimacy. Unfortunately, there are no reported interventions that
have been successful in reducing the impact of SD on long term couple health-related quality
of life.
Project Description: Men and their partners need an effective intervention to help them adapt
to sexual dysfunction following prostate cancer surgery. In addressing this need we propose
an innovative biomedical-psychosocial Intervention that emphasizes: 1) multidisciplinary
intervention teams; 2) the active participation of the partner; and 3) a broad-spectrum
medical, psychological, and social approach. The treatment goal of the intervention is to
promote intimacy and optimal sexual health in affected couples. This is a preliminary study
designed to determine the feasibility of running a large scale randomized controlled trial
comparing the new biomedical-psychosocial intervention to an attention control condition.
Impact and Relevance: The burden of sexual dysfunction after prostate cancer surgery is
responsible for the single greatest impact on patient/partner health-related quality of life;
substantially more so than concern for cancer recurrence, or any other post-surgery
side-effect. Consequently, there is a great need for progressive and distributable sexual
health rehabilitation interventions designed to uphold intimacy and optimal sexual health. If
the biomedical-psychosocial intervention is ultimately found beneficial, it will result in:
1) an empirically-based intervention that helps patients/partners maintain optimal
health-related quality of life after prostate cancer surgery, and 2) a highly structured
protocol and manualized intervention that is translatable to other treatment groups (e.g.
radiation therapy) and University/Community-based hospitals.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05540392 -
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
|
Phase 1/Phase 2 | |
Recruiting |
NCT05613023 -
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
|
Phase 3 | |
Recruiting |
NCT05156424 -
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT03177759 -
Living With Prostate Cancer (LPC)
|
||
Completed |
NCT01331083 -
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT05540782 -
A Study of Cognitive Health in Survivors of Prostate Cancer
|
||
Active, not recruiting |
NCT04742361 -
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
|
Phase 3 | |
Completed |
NCT04400656 -
PROState Pathway Embedded Comparative Trial
|
||
Completed |
NCT02282644 -
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
|
N/A | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06305832 -
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT05761093 -
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
|
||
Completed |
NCT04838626 -
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
|
Phase 2/Phase 3 | |
Recruiting |
NCT03101176 -
Multiparametric Ultrasound Imaging in Prostate Cancer
|
N/A | |
Completed |
NCT03290417 -
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Completed |
NCT01497925 -
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
|
Phase 1 | |
Recruiting |
NCT03679819 -
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
|
||
Completed |
NCT03554317 -
COMbination of Bipolar Androgen Therapy and Nivolumab
|
Phase 2 | |
Completed |
NCT03271502 -
Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy
|
N/A |